Vifor Pharma has announced its board of directors will propose Åsa Riisberg for election to the board at the Annual General Meeting on 6 May 2021.
Riisberg, a Swedish citizen, was formerly partner and member of the extended executive committee of the private equity firm EQT. She has served on various international boards with current board seats at Atlas Antibodies, Netcompany, F-Secure, Dagens Nyheter, Bonnier News and Bonnier Capital as well as at the Women in Finance Foundation. She’s also an Advisory Board Member at the Stockholm School of Economics and member of the investment committee at Cinder Invest. She holds a MSc in Financial Economics and Business Administration from Stockholm School of Economics.
Jacques Theurillat, Chairman of Vifor Pharma, said: “We are very pleased that Åsa Riisberg will bring her expertise to the Board of Directors. Her broad knowledge and experience, particularly in the areas of investment management and operations are extremely valuable for Vifor Pharma. She will ideally complement the Board to assess the company’s business development and inorganic growth plans, aiming to become the global leader in iron deficiency, nephrology and cardio-renal therapies.”
